These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16926849)

  • 1. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
    Marteijn JA; Jansen JH; van der Reijden BA
    Leukemia; 2006 Sep; 20(9):1511-8. PubMed ID: 16926849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative UPS drug targets upstream the 26S proteasome.
    Hjerpe R; Rodríguez MS
    Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
    Yerlikaya A; Kanbur E; Stanley BA; Tümer E
    Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
    Motegi A; Murakawa Y; Takeda S
    Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of proteasome complexes and ubiquitinated proteins.
    Wang X; Guerrero C; Kaiser P; Huang L
    Expert Rev Proteomics; 2007 Oct; 4(5):649-65. PubMed ID: 17941820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases.
    Hynes-Smith RW; Wittorf KJ; Buckley SM
    Trends Immunol; 2020 Dec; 41(12):1128-1140. PubMed ID: 33160841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
    Schmidtke G; Kalveram B; Groettrup M
    FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the proteasome in ethanol-induced liver pathology.
    Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of proteasome degradation by multi-ubiquitin chain binding proteins.
    Miller J; Gordon C
    FEBS Lett; 2005 Jun; 579(15):3224-30. PubMed ID: 15943965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.
    Yang Y; Kitagaki J; Dai RM; Tsai YC; Lorick KL; Ludwig RL; Pierre SA; Jensen JP; Davydov IV; Oberoi P; Li CC; Kenten JH; Beutler JA; Vousden KH; Weissman AM
    Cancer Res; 2007 Oct; 67(19):9472-81. PubMed ID: 17909057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.
    Heuzé ML; Lamsoul I; Moog-Lutz C; Lutz PG
    Blood Cells Mol Dis; 2008; 40(2):200-10. PubMed ID: 17919948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry and biology of the ubiquitin signal.
    Spasser L; Brik A
    Angew Chem Int Ed Engl; 2012 Jul; 51(28):6840-62. PubMed ID: 22696461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
    Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
    Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
    Wyke SM; Tisdale MJ
    Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin and ubiquitin-like proteins as multifunctional signals.
    Welchman RL; Gordon C; Mayer RJ
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):599-609. PubMed ID: 16064136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligases in B-cell malignancies.
    Choi J; Busino L
    Cell Immunol; 2019 Jun; 340():103905. PubMed ID: 30827673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.